CS802186A2 - Method of substituted imidazopyridine derivatives production - Google Patents

Method of substituted imidazopyridine derivatives production

Info

Publication number
CS802186A2
CS802186A2 CS868021A CS802186A CS802186A2 CS 802186 A2 CS802186 A2 CS 802186A2 CS 868021 A CS868021 A CS 868021A CS 802186 A CS802186 A CS 802186A CS 802186 A2 CS802186 A2 CS 802186A2
Authority
CS
Czechoslovakia
Prior art keywords
opt
alkyl
substd
alkoxy
etherified
Prior art date
Application number
CS868021A
Other languages
English (en)
Other versions
CS268687B2 (en
Inventor
Leslie J Dr Browne
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/622,421 external-priority patent/US4617307A/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to CS868021A priority Critical patent/CS268687B2/cs
Publication of CS802186A2 publication Critical patent/CS802186A2/cs
Publication of CS268687B2 publication Critical patent/CS268687B2/cs

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS868021A 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production CS268687B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS868021A CS268687B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/622,421 US4617307A (en) 1984-06-20 1984-06-20 Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
CS854449A CS268672B2 (en) 1984-06-20 1985-06-18 Method of substituted imidazo-(1,5-a)pyridine derivatives production
CS868021A CS268687B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production

Publications (2)

Publication Number Publication Date
CS802186A2 true CS802186A2 (en) 1989-07-12
CS268687B2 CS268687B2 (en) 1990-04-11

Family

ID=25745999

Family Applications (3)

Application Number Title Priority Date Filing Date
CS868019A CS268685B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868018A CS268684B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868021A CS268687B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyridine derivatives production

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CS868019A CS268685B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
CS868018A CS268684B2 (en) 1984-06-20 1986-11-05 Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production

Country Status (1)

Country Link
CS (3) CS268685B2 (cs)

Also Published As

Publication number Publication date
CS268684B2 (en) 1990-04-11
CS268687B2 (en) 1990-04-11
CS268685B2 (en) 1990-04-11
CS801986A2 (en) 1989-07-12
CS801886A2 (en) 1989-07-12

Similar Documents

Publication Publication Date Title
HK6392A (en) Podophyllotoxin derivatives
Cohen et al. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide
DK0585242T3 (da) Sårheling
NO870407D0 (no) Anti-histaminblandinger inneholdende n-heterocyklyl-4-piperidinaminer.
HRP20010119B1 (hr) Sprječavanje stvaranja sluzi u dišnim putevima primjenom antagonista egf-r
DE3650499D1 (de) Verwendung von "Cartilage-inducing Factor" (CIF) zur Behandlung von hemato- oder lymphopoietischen Krankheiten
Zhang On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
LU90128I2 (fr) Létrozole et ses sels et dérivés pharmaceutiquement acceptables (Femara)
Cassin et al. The effects of bumetanide and furosemide on lung liquid secretion in fetal sheep
HUP0001162A2 (hu) Pirrolo-benzodiazepin-, -kinoxalin-, -pirazin-származékok és az ezeket tartalmazó gyógyszerkészítmények
ATE223228T1 (de) Verwendung von latenz assoziierten peptiden in der herstellung eines medikaments zur verbesserung der wundheilung.
NZ333063A (en) Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors
CS802186A2 (en) Method of substituted imidazopyridine derivatives production
CS802086A2 (en) Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production
GB8818356D0 (en) 1,4-dihydropyridines their preparation & medicinal use
NO880731L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
Blijham et al. Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.
FI98369B (fi) Menetelmä valmistaa farmaseuttisesti aktiivista 1- tai 3-difenyylimetyyli-imidatsoindolitsiinijohdannaista
Cuevas et al. Dobesilate is an angiogenesis inhibitor
DK0533210T3 (da) Protein C-holdige farmaceutiske præparater som midler mod inflammation.
Livingston et al. Sequential Combination Chemotherapy for Advanced, Recurrent, Squamous Carcinoma of the Head and
Tomono et al. Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts
Parr et al. Immunohistochemically-defined subtypes of neurons in the inferior mesenteric ganglion of the guinea-pig
AU3818989A (en) The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages
DE3889497D1 (de) 3,4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-e]-1,2-thiazine-4-carboxamid-1,1-dioxide.

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20000618